Objective To review the published literature on the performance of indirect
immunofluorescence (IIF)–HE p‐2 antinuclear antibody (ANA) testing for classification of …

Objective This study aimed to review and compare the diagnostic accuracy of the screening
enzyme immunoassay (SEIA) and indirect immunofluorescence (IIF) as anti-nuclear …

Background The 2019 classification criteria for systemic lupus erythematosus (SLE) includes
an initial criterion requiring the presence of an antinuclear antibody (ANA), positive at a titer …

Background: Systemic lupus erythematosus (SLE) is a multisystem, chronic but often
episodic, autoimmune disease that is characterized by the presence of antinuclear …

Despite the expansion of available in vitro laboratory tests at a rate far exceeding that of
dermatologic pharmaceuticals, the existing literature is dominated by discussion of the latter …

Background: Connective tissue disorders (CTD's) are a group of autoimmune disorders
having multifactorial etiology, multisystem involvement and overlapping clinical features …

Background Testing for antinuclear antibodies (ANA) is useful for the diagnosis of
autoimmune connective tissue diseases (CTD). Solid-phase assay such as the enzyme …

In order to evaluate the performance of the chemiluminescent immunoassay (CLIA) in
antinuclear antibodies (ANA) testing, using indirect fluorescent antibody (IFA) on HEp-2 cells …

OBJETIVO: Avaliar o desempenho de um imunoensaio quimioluminescente (CLIA) para os
anticorpos anti-dsDNA, utilizando como referência o teste de imunofluorescência indireta …

Background: Anti-nuclear antibodies (ANAs) are specific antibodies directed against a
variety of nuclear antigens. Indirect immunofluorecence (ANA-IFA) and Enzyme …